Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-02-06
2007-02-06
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S825000, C424S093400, C530S825000, C530S350000
Reexamination Certificate
active
09489711
ABSTRACT:
The invention relates to stabilized antigen compositions ofErysipelothrix rhusiopathiaeand vaccine formulations containing such antigen compositions. Antigens of the invention are effective in providing long-term protection against erysipelas in animals.
REFERENCES:
patent: 3962421 (1976-06-01), Neurath
patent: 4709017 (1987-11-01), Collier et al.
patent: 5069901 (1991-12-01), Jones et al.
patent: 5695769 (1997-12-01), Frantz et al.
patent: 5895655 (1999-04-01), Eckhardt et al.
patent: 6013264 (2000-01-01), Petre et al.
patent: 6111089 (2000-08-01), Fukuda
patent: 6156337 (2000-12-01), Barenholz et al.
patent: 6277379 (2001-08-01), Oaks et al.
patent: 6358744 (2002-03-01), Volkin et al.
patent: 6372225 (2002-04-01), Matsuda
patent: 6777405 (2004-08-01), Barton et al.
patent: 2006/0173060 (2006-08-01), Chang et al.
patent: WO 91/18627 (1991-12-01), None
Wild RL. J. Am. Vet. Med. Assoc. 184: 944-949, 1984.
Rappuoli R. Vaccine 12: 579-581, 1994.
Zarkasie et al. J. Vet. Med. Sci. 58: 87-89, 1996.
Sato, H., et al., Protective Activity and Antigenic Analysis of Fractions of Culture Filtrates ofErysipelothrix rhusiopathiae, Veterinary Microbiology, vol. 43, No. 2-3, 1995, pp. 173-182.
Timoney J. F. And Groschup M. M., Properties of a Protective Protein Antigen ofErysipelothrix rhusiopathiae, Veterinary Microbiology, vol. 37, No. 3-4, 1993, pp. 381-387.
Kobayashi, S. et al., Immunological Characterization of Protective Antigens Prepared by Alkaline Treatment of Whole Cells and From the Culture Filtrate ofErysipelothrix, Veterinary Microbiology, vol. 30, 1992, pp. 73-85.
Chemical Abstract Service of Takagi, H., et al., Recombinant Preparation of Protective Peptide Antigen and Use as Vaccine AgainstErysipelothrix rhusiopathiae, Database Accession No. 133:149129.
Groschup, M. H., et al., Characterization of a Protective Protein Antigen ofErysipelothrix rhusiopathiae, Epidemiol. Infect., 107, 1991, pp. 637-649.
Sawada, T. And Takahashi, T., Cross Protection of Mice and Swine Inoculated with Culture Filtrate of AttenuatedErsipelothrix rhusiopathiaeand Challenge Exposed to Strains of Various Serovars, Am J. Vet Res, vol. 48, No. 2, Feb. 1987, pp. 239-242.
McCutcheon's, Emulsifiers & Detergents, North American Edition, 1987 (McCutcheon Division, MC Publishing Co., Glen Rock, NJ).
Roberts David S.
Suiter Brian T.
Swearingin Leroy A.
Devi S.
Gumbleton Timothy J.
Pfizer Inc.
LandOfFree
Erysipelothrix rhusiopathiae antigens and vaccine compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erysipelothrix rhusiopathiae antigens and vaccine compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erysipelothrix rhusiopathiae antigens and vaccine compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853720